Anticipating The FDA's Shift Away From Emergency Approvals

Law360 (July 22, 2021, 5:41 PM EDT) -- Emergency use authorizations will play a role as the pandemic eases, but a transition to ordinary course approvals is underway.

The coronavirus pandemic prompted an unprecedented reliance on emergency use authorizations by the U.S. Food and Drug Administration for a variety of medical devices and treatments.

During a public health emergency, as stated on its website, the FDA can issue EUAs to "allow the use of unapproved medical products, or unapproved uses of approved medical products, to diagnose, treat, or prevent serious or life-threatening diseases when certain criteria are met, including that there are no adequate, approved, and available alternatives."...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!